在帕金森病的表观遗传修饰.
Hao Song1,2, Juanli Chen2, Jin Huang3
1The Innovation Institute for Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Frontiers in cell and developmental biology
|June 23, 2023
概括
表观遗传修饰,包括DNA甲基化和基因组变化,是帕金森病 (PD) 发病的关键. 了解这些表观遗传机制为PD提供了新的诊断和治疗点.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 帕金森病 (PD) 是一种常见的神经退行性疾病,具有复杂的病因.
- 遗传,表观遗传和环境因素都会导致PD的发展.
- 最近的进展凸显了表观遗传学在PD中的重要作用.
研究的目的:
- 审查目前对帕金森病表观遗传机制的理解.
- 讨论表观遗传变化如何影响PD中的基因表达和神经退行.
- 确定PD治疗和预防的新兴表观遗传标和生物标志物.
主要方法:
- 审查关于表观遗传学和帕金森病的当前科学文献.
- 对表观遗传修饰的分析,如DNA甲基化,基因质修饰,染色质重塑和基于RNA的机制.
- 讨论这些机制在神经元发育和神经退行过程中的作用.
主要成果:
- 表观遗传修饰是细胞功能和神经元过程的组成部分.
- 改变DNA甲基化,基因组修饰,染色质重塑和RNA功能都与PD有关.
- 这些表观遗传变化影响神经元发育和神经退行.
结论:
- 表观遗传机制在帕金森病的发病过程中至关重要.
- 新兴的表观遗传标显示出新治疗策略的前景.
- 表观遗传生物标志物可以帮助诊断和监测PD.
更多相关视频
08:33Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
7.5K
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.6K
相关概念视频
Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
